IL2 and neoplasm: In addition, the molecular and biochemical mechanisms of IL-2-mediated activation of endothelial cells could be investigated in vitro and in vivo on several types of tumor-associated cells (e.g., tumor-associated endothelial cell and tumor-associated fibroblast) expressing the different chains of IL-2R; this could be potentially exploited for the treatment of tumors.